Stage IV Primary Peritoneal Cavity Cancer
7 clinical trials · Condition
◉ Watch Stage IV Primary Peritoneal Cavity Cancer
| Record | Firm | Date |
|---|---|---|
| Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT02122185) | University of Chicago | 2015-02-25 |
| Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer (NCT01536054) | Roswell Park Cancer Institute | 2012-08-20 |
| Sunitinib Malate in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer (NCT00388037) | National Cancer Institute (NCI) | 2007-01-01 |
| AFP464 in Treating Patients With Metastatic or Refractory Solid Tumors That Cannot Be Removed By Surgery (NCT00348699) | National Cancer Institute (NCI) | 2006-07-01 |
| Cisplatin and Flavopiridol in Treating Patients With Advanced Ovarian Epithelial Cancer or Primary Peritoneal Cancer (NCT00083122) | National Cancer Institute (NCI) | 2004-04-01 |
Track Stage IV Primary Peritoneal Cavity Cancer automatically
Every clearance here is in the API, with alerts when new ones post.